MariMed Inc. (MRMD) Misses Q2 EPS by 1c ; Offers Guidance

MariMed Inc. (OTC: MRMD) reported Q2 EPS of ($0.01), $0.01 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $38.8 million versus the consensus estimate of $39.6 million.

GUIDANCE:

MariMed Inc. sees FY2023 revenue of $148-150 million, versus the consensus of $152.3 million.

For earnings history and earnings-related data on MariMed Inc. (MRMD) click here.

You May Also Be Interested In

• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
• Baidu (BIDU) Misses Q2 EPS by 262c, misses on revenue
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c